BEGIN:VCALENDAR
METHOD:CANCEL
PRODID:Microsoft Exchange Server 2010
VERSION:2.0
BEGIN:VTIMEZONE
TZID:Central Standard Time
BEGIN:STANDARD
DTSTART:16010101T020000
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
RRULE:FREQ=YEARLY;INTERVAL=1;BYDAY=1SU;BYMONTH=11
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:16010101T020000
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
RRULE:FREQ=YEARLY;INTERVAL=1;BYDAY=2SU;BYMONTH=3
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
ORGANIZER;CN=Jorg Stetefeld:MAILTO:[email protected]
ATTENDEE;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=hraaijmake
 [email protected]:MAILTO:[email protected]
ATTENDEE;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=CCP4BB@JIS
 CMAIL.AC.UK:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Paula Salg
 ado:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=John Willi
 ams:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Ing, Gabri
 el B":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Park, Yang
 shin":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=liujiwei02
 [email protected]:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=David Scot
 t:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Francis Ac
 quah:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Pavšič, 
 Miha":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=JAMES NOBL
 E:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Nick Keep:
 MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=El Sahili 
 Abbas (Dr):MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Schertler 
 Gebhard (PSI):MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Lizbe Koek
 emoer:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Guillermo 
 Montoya:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Diana Silv
 a:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Jing Dong:
 MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=ukleja.mar
 [email protected]:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Mooers, Bl
 aine H.M.  (HSC)":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Jose Edwin
  Neciosup Quesñay:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Diana Mont
 eiro:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Brian Mark
 :MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Lisa Baker
 :MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Barondeau,
  David P":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Takagi, Yu
 ichiro":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Oganesyan,
  Vaheh":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Mario van 
 Zeeland:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=dqujhernan
 [email protected]:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=sara.pinta
 [email protected]:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Roach P.L.
 :MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Mark Roe:M
 AILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Hazard, E.
  Starr":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Mukhopadhy
 ay, Shreya":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Guo, Jingx
 u":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=shukuri12@
 gmail.com:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Patra, Dha
 baleswar":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Chazin, Wa
 lter J":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=julio baca
 rizo roa:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=marykjohns
 [email protected]:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Fernandez,
  Elias J":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=bo18mtech1
 [email protected]:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Tanner, Jo
 hn J.":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Hudson, Wi
 lliam Harris":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Isabel Mor
 aes:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Tom Calcra
 ft:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Kumar, Dil
 ip":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Chandra Ve
 rma:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=jaggabiksh
 [email protected]:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Samuel Blo
 or:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Kokkinidou
 , Maria":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Deng, Junp
 eng":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Arnaud Bas
 le:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Lavie, Arn
 on":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=umarfarook
 [email protected]:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Lin, David
  Y [BBMB]":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Hough, Mik
 e":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Laura Spag
 nolo:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Ekaterina 
 Morgunova:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Julia Sanz
 :MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=william le
 e:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Stephen Mu
 ench:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Allan Surg
 enor:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Francesca 
 Mattiroli:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Yael Diski
 n Posner:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Abimael Cr
 uz Migoni:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=deepanshui
 [email protected]:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Weijiang Z
 hou:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Lengyel, J
 effrey":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Brick, Pet
 er":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Andrew Tho
 mpson:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Klein, Dan
 iel Joseph":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=gyanamahap
 [email protected]:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=hussaingps
 @gmail.com:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Lindsay Sa
 wyer:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Rudolph, M
 arkus":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Tobias Kro
 jer:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Janssen, B
 .J.C. (Bert)":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=jpatsxc@gm
 ail.com:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Pojer Flor
 ence:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=soumen.das
 [email protected]:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=zhen xu:MA
 ILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Giuseppe C
 iossani:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Derek Loga
 n:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Buchanan, 
 Susan (NIH/NIDDK) [E]":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Nicola G A
  Abrescia:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Benning, M
 atthew":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=tiru.hcu09
 @gmail.com:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=rddey80@gm
 ail.com:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Juan Mendo
 za:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=hypowergra
 [email protected]:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Wojdyla Ju
 styna Aleksandra (PSI):MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=dohnalek00
 [email protected]:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Marco  BEL
 LINZONI:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Dima Chirg
 adze:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=jyin@ualbe
 rta.ca:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Michael We
 yand:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Ailong Ke:
 MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Dunham, Ch
 ristine":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Hruza, Ala
 n":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Derek Ogg:
 MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Ragan, Tj 
 (Dr.)":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=smita@rcb.
 res.in:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Clausen,Ti
 m":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Urs Jenal:
 MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=V. Nagaraj
 an:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Micelli, C
 armina":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Müller, U
 we":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Pletnev, S
 ergei V.":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Emmanuel S
 kordalakes:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=filipe.mig
 [email protected]:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=xjtuhw@gma
 il.com:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Marcelo Ca
 rlos Sousa:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=史 沙沙
 :MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Raghurama 
 P Hegde:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Capper, Mi
 chael":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Pearce, N.
 M. (Nick)":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN="Chari, Ash
 win":MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Yogesh Kul
 athu (Staff):MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=Robert Kee
 nan:MAILTO:[email protected]
ATTENDEE;ROLE=OPT-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=TRUE;CN=nkuwabara0
 [email protected]:MAILTO:[email protected]
DESCRIPTION;LANGUAGE=en-US:\n
UID:040000008200E00074C5B7101A82E008000000009A6A77619C3DD601000000000000000
 010000000FA9E141292FFB14EBE217E5DF662FCF9
SUMMARY;LANGUAGE=en-US:Canceled: [ccp4bb] Cryo-EM for Drug Discovery | Virt
 ual event | June 16\, 2020
DTSTART;TZID=Central Standard Time:20200609T013124
DTEND;TZID=Central Standard Time:20200609T020124
CLASS:PUBLIC
PRIORITY:1
DTSTAMP:20200608T155205Z
TRANSP:TRANSPARENT
STATUS:CANCELLED
SEQUENCE:1
LOCATION;LANGUAGE=en-US:
X-MICROSOFT-CDO-APPT-SEQUENCE:1
X-MICROSOFT-CDO-OWNERAPPTID:2118535066
X-MICROSOFT-CDO-BUSYSTATUS:FREE
X-MICROSOFT-CDO-INTENDEDSTATUS:FREE
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
X-MICROSOFT-CDO-IMPORTANCE:2
X-MICROSOFT-CDO-INSTTYPE:0
X-MICROSOFT-DONOTFORWARDMEETING:FALSE
X-MICROSOFT-DISALLOW-COUNTER:FALSE
END:VEVENT
END:VCALENDAR

Reply via email to